Apollo Hospitals ltd
Apollo Hospitals Strong Financial Growth: A Look at India’s Leading Healthcare Provider

Business and Industry Overview: 

Apollo Hospitals started in 1983 in Chennai, India, by Dr. Prathap C. Reddy. It was the first private hospital of its kind in India. It changed healthcare in India by offering better care and treatments. Today, Apollo has 71 hospitals in India. It is the biggest private hospital chain in the country. These hospitals are in big cities like Chennai, Hyderabad, Bengaluru, Kolkata, Delhi, and Ahmedabad. Apollo offers care for many problems like heart disease, bone problems, brain issues, and cancer. Apollo is known for treating serious health problems. They use the latest technology and have doctors from all over the world. Many people trust Apollo for good care. Apollo is growing. They plan to add over 2,000 more beds in their hospitals by 2027. This will help more people get care. Apollo also helps train doctors, nurses, and healthcare workers. They also do research to find better treatments. In 2024, Apollo made 63% more money than the previous year. This is because more people are using their services. Apollo’s goal is to give the best care, keep patients safe, and use technology to improve health. They want to make healthcare affordable for everyone in India and other countries. 

Latest Stock News: 

Apollo Hospitals’ stock dropped by 6.7% on April 11, 2025, because the overall stock market went down. This drop was not due to problems with Apollo itself. Despite this, Apollo is still one of the biggest and most important healthcare companies in India. Apollo is planning to grow a lot in the next few years. They are going to invest ₹6,000 crore to add 3,500 new hospital beds over the next five years. This will help Apollo meet the growing demand for healthcare. In the first phase, they will spend ₹2,880 crore to add 1,737 beds in big cities like Pune, Kolkata, Hyderabad, and Gurgaon. They plan to complete this by 2026. In the second phase, Apollo will add 1,775 more beds in cities like Chennai, Mumbai, Varanasi, and Lucknow. This will help more people in both big and small cities get better healthcare. Apollo’s plan to add more beds shows that the company is working to make healthcare easier for more people in India. Even though their stock went down recently, Apollo’s growth plans show they have a strong future. 

Potentials: 

Apollo Hospitals has big plans for the future. They want to spend ₹6,100 crore to grow and help more people. They plan to add 3,500 new beds in 11 places across India by 2026. This will allow Apollo to treat more patients and give them better care. Apollo will open five new hospitals in big cities like Mumbai, Chennai, Gurgaon, Varanasi, and Lucknow. These hospitals will have over 1,400 beds. They will also make their current hospitals bigger in cities like Pune, Kolkata, and Hyderabad. This will provide more space for patients and doctors. Apollo will spend ₹1,700 crore for this expansion. Out of this, ₹1,300 crore will be spent in the next year. This shows that Apollo is serious about improving healthcare in India. 

Apollo is also improving their online services. They want to make it easier for people to talk to doctors. Through telemedicine and online consultations, people can talk to doctors from home. This will help people who cannot visit a hospital easily. These plans will help Apollo provide better healthcare. It will also help treat more people across India. Apollo is working hard to make healthcare available for everyone. 

Analyst Insights: 

  • Market capitalisation: ₹ 99,147 Cr. 
  • Current Price: ₹ 6,896 
  • 52-Week High/Low: ₹ 7,545 / 5,691 
  • Stock P/E: 75.6 
  • Dividend Yield: 0.24% 
  • Return on Capital Employed (ROCE): 15.1% 
  • Return on Equity: 13.3% 

Apollo Hospitals is a strong company with solid financial growth. Over the last five years, its profits have grown by 34.3% each year on average. This shows it can keep growing in the future. The company has been able to increase both its revenue and profit margins, even during difficult times. In Q4 FY24, Apollo Hospitals reported a 51.77% increase in net profit, reaching ₹379 crore. This is a big jump and shows the company is still doing well despite challenges. The operating profit margin is 14%, which means Apollo is good at controlling its costs. Apollo’s return on capital employed (ROCE) is 15.1%, which shows it uses its money effectively to make more profit. Its return on equity (ROE) is 13.3%, which means it uses shareholders’ money well to earn profits. The company has a large network of 10,134 beds across India and abroad. This helps it cover a large part of the healthcare market. It also helps the company make more revenue. The healthcare industry is growing, and Apollo is in a good position to take advantage of this. 

Apollo Hospitals also pays a dividend of 22.6%. This is attractive for investors who want regular income. So, Apollo is a good choice for investors looking for both growth and income. 

The company’s price-to-earnings (P/E) ratio is 75.6, which is higher than many other companies. This shows that investors expect Apollo to keep growing. Even with the high P/E ratio, it makes sense because Apollo is a leader in the healthcare field. Its high-margin services, like specialized care and retail drugs, are doing well. 

Overall, Apollo Hospitals is a strong choice for investors. It has shown good financial growth, is well-managed, and is a leader in the healthcare market. Investors looking for long-term growth in healthcare should consider Apollo Hospitals. 

Apollo Hospitals Ltd
Apollo Hospitals Q3 Results: 52% Profit Surge, ₹9 Dividend, Revenue Up 14%

Business and Industry Overview: 

Apollo Hospitals was founded in 1983 by Dr. Prathap C. Reddy, widely recognized as the architect of modern healthcare in India. As the country’s first corporate hospital, Apollo Hospitals pioneered the private healthcare revolution and has since evolved into Asia’s leading integrated healthcare services provider. The group has a strong presence across the healthcare ecosystem, including hospitals, pharmacies, primary care and diagnostic clinics, and various retail health models. Additionally, it offers telemedicine services across multiple countries, health insurance solutions, global project consultancy, medical colleges, e-learning through Medvarsity, and specialized colleges for nursing and healthcare management. Its research foundation and initiatives like ‘ASK Apollo’—an online consultation portal—and Apollo Home Health further enhance its service offerings. 

Apollo Hospitals has been at the forefront of introducing cutting-edge medical innovations in India, leveraging rapid advancements in medical technology. Notably, Southeast Asia’s first proton therapy center began operations at the Apollo Center in Chennai. 

The organization has also launched several social initiatives aimed at supporting underprivileged children, including: 

  • SACHi (Save a Child’s Heart Initiative): Focused on pediatric cardiac care for congenital heart diseases. 
  • SAHI (Society to Aid the Hearing Impaired): Provides support for children with hearing disabilities. 
  • CURE Foundation: Dedicated to cancer care. 
  • Total Health Foundation: A unique population health model piloted in Thavanampalle Mandal, Andhra Pradesh, offering holistic healthcare from birth through old age. 

The industry includes hospitals, medical devices, health insurance, and more The healthcare sector has been growing at a compound annual growth rate of around 22% since 2016.  In 2022, the healthcare industry was valued at over $370 billion, and the sector is expected to reach over $610 billion by 2026. Apollo Hospitals is  India’s largest for-profit private hospital network with 71 owned and managed hospitals. Through its subsidiaries, it also runs pharmacies, primary care and diagnostic centers, telehealth clinics, and digital healthcare services. India’s healthcare industry is one of the country’s largest sectors, employing millions of people and contributing billions of dollars to the economy. 

Latest Stock News: 

Apollo Hospitals reported a 52% year-on-year (YoY) increase in net profit, reaching ₹372 crore for the third quarter ended December 31, 2024. Revenue grew 14% YoY to ₹5,527 crore. The company’s board declared an interim dividend of ₹9 per share, setting February 15 as the record date, with payment scheduled on or before February 28, 2025

Despite meeting analysts’ estimates with a 14% revenue growth in Q3 FY25, Apollo Hospitals’ shares declined 4.5%. The company remains focused on expanding its healthcare services and technology capabilities. 

Additionally, Apollo Hospitals announced plans to add 3,512 beds over the next 3 to 4 years, starting FY26

Segmental information: 

Apollo Hospitals operates across multiple business segments, making it one of India’s most diversified healthcare providers. 

Healthcare Services 

Apollo runs 71 hospitals across India, offering multispecialty and superspecialty care in cardiology, oncology, neurology, orthopedics, and transplants. It has introduced advanced medical technologies, including robotic-assisted surgeries and South East Asia’s first Proton Therapy Centre in Chennai. 

Pharmacy & Digital Healthcare 

Apollo Pharmacy, India’s largest retail pharmacy chain, has 5,000+ stores across 21 states, providing prescription drugs, OTC medicines, and wellness products. Its digital platform, Apollo 24/7, offers teleconsultations, e-pharmacy, and home diagnostics, leveraging AI for personalized healthcare. 

Primary & Secondary Care 

Apollo Health and Lifestyle operates Apollo Clinics, Apollo Diagnostics, Apollo Sugar (diabetes care), Apollo White (dental), Apollo Cradle (women & child care), Apollo Fertility, and Apollo Dialysis, extending care beyond hospitals. 

Telehealth Services 

Apollo TeleHealth provides remote healthcare through B2C, B2B, and B2G models, partnering with government programs to improve healthcare access in rural areas. Established in 1999, it operates 100+ teleclinics across India. 

Health Insurance & Wellness 

Previously operating Apollo Munich Health Insurance (now merged with HDFC Ergo), Apollo continues to support corporate and individual health insurance solutions. 

Education & Research 

Apollo Medvarsity, an e-learning platform, trains medical professionals, while the Apollo Research Foundation focuses on clinical trials and medical research. 

International Healthcare Projects 

Apollo provides global healthcare consultancy, recently signing an MoU with Indonesia’s Mayapada Healthcare Group to enhance oncology, cardiology, neurology, and transplant services. 

With its integrated network of hospitals, pharmacies, digital healthcare, and research, Apollo Hospitals continues to drive innovation and accessibility in healthcare.  

Subsidiary Information: 

  • Apollo HealthCo (formed in 2021) integrates the group’s non-hospital pharmacy chain Apollo Pharmacy with its digital healthcare platform Apollo 24/7
  • Apollo Pharmacy: India’s largest retail pharmacy chain, operating over 5,000 stores across 21 states. Established in 1987
  • Apollo 24/7: The group’s digital healthcare platform, launched in 2020, offering telehealth consultations, online medicine orders, home diagnostics, and more
  • Apollo Health and Lifestyle: The group’s primary and secondary care arm, which operates: 
  • Apollo Clinics: Multi-specialty clinics. 
  • Apollo Diagnostics: Pathology and diagnostic labs. 
  • Apollo Sugar: Diabetes management clinics. 
  • Apollo White: Dental hospitals. 
  • Apollo Dialysis: Dialysis centers. 
  • Apollo Spectra: Minimally invasive surgical hospitals. 
  • Apollo Cradle: Women and children’s hospitals. 
  • Apollo Fertility: Fertility clinics. 
  • Apollo TeleHealth Services: 
  • Manages the group’s telehealth network via multiple models: 
  • Business-to-Consumer (B2C): Direct services like online consultations, appointment booking, and medicine delivery. 
  • Business-to-Business (B2B): Corporate telehealth services. 
  • Business-to-Government (B2G): Telehealth partnerships with public healthcare systems. 
  • Established in 1999, headquartered in Hyderabad, with over 100 franchised teleclinics

Q3 Highlights: 

  • PAT jumps 52% YoY to Rs 372 crore, revenue rises 14%; Rs 9 per share dividend declared 
  • declared an interim dividend of Rs 9 per share and fixed February 15 as the record date for the same. 
  • Apollo Hospitals’ consolidated profit rose 51.8 per cent year-on-year (Y-o-Y) to Rs 372.3 crore in Q3FY25, from Rs 245.3 crore in the same quarter previous fiscal year (Q3FY24) 

Financial Summary: 

Amount in ₹ Cr Q3 FY24 Q3 FY25 FY23 FY24 
Revenue 4,851.00 5,527.00 16,612 19,059 
Expenses 4,237 4,765 14,548 16,665 
EBITDA 643 831.00 2,140.00 2,498.00 
OPM 13% 14% 12% 13% 
Other Income 29 69 75 105 
Net Profit 254.00 379.00 844 935 
NPM 5.24 6.86 5.08 4.91 
EPS 17.06 25.89 56.97 62.5